Session Keynote Speakers
Dr. Mark Allenby, Queensland University of Technology (QUT)
Dr Mark C Allenby is a Lecturer and Advance Queensland research fellow at Queensland University of Technology coupling tissue systems models and bioimage analyses to engineer improved medical treatments using experimental and computational approaches. Allenby is an investigator in the Herston Biofabrication Institute at the Royal Brisbane & Women's Hospital in Australia. URL: https://staff.qut.edu.au/staff/mark.allenby.
Prof. Paula M Alves, iBET - instituto Biologia Experimental e Tecnologica
Paula Alves is the CEO of iBET and Professor at NOVA University of Lisbon; She holds a Ph.D. in Biochemical Engineering and a BSc in Biochemistry; Working in Animal Cell Technology since 1990, Professor Alves’ research integrates cell metabolism understanding with biochemical engineering for the improvement of bioprocesses for production of biopharmaceuticals, also focusing on the development of new tools for pre-clinical research. She is currently the President of the European Society for Animal Cell Technology. Published over 250 papers, 35 book chapters, supervised 36 PhD students. In 2009 she received the Scientific Merit Award from NOVA University of Lisbon.
Prof. Conor T Buckley, Trinity College Dublin
Conor Buckley is Principal investigator (PI) in the Trinity Centre for Biomedical Engineering and the Advanced Materials and Bioengineering Research (AMBER) Centre at Trinity College Dublin, Ireland. His research focuses on novel biomaterials, biofabrication and cell-based strategies for tissue regeneration (https://www.buckleylab.eu/). He has published 70 international peer reviewed journal articles and over 180 conference publications. He recently received a European Research Council Award (ERC) Consolidator award to develop personalised medicine approaches to regenerating the intervertebral disc using gene activated biomaterials and in silico predictive modelling.
Prof. Joaquim Cabral, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal
Joaquim Cabral is a Distinguished Professor of Instituto Superior Técnico, University of Lisbon, Portugal. He was the Founding Head of Department of Bioengineering and Founding Director of the Institute for Bioengineering and Biosciences. He is graduated in Chemical Engineering with a PhD and “Habilitation” degrees in Biochemical Engineering in 1983 and 1988, respectively. He was a post-doctoral fellow at Massachusetts Institute of Technology (1983-1984). He joined IST faculty as Assistant Professor in 1984 and became Associate Professor in 1987 and Full Professor of Chemical and Biological Engineering in 1992. He has authored more than 580 publications (WoS h index 55).
Prof. dr. Antonio Campos, Departmen of Histolgy, School of Medicine University of Granada, Spain
Antonio Campos is Full Professor of Histology at the University of Granada. He has been president of the Spanish Society of Histology, Dean and director of the National Institute of Health Carlos III where he promoted new models of biomedical investigation programs. Promoter of tissue engineering, his group has created artificial tissues that have already been transferred to the clinic. He has published relevant books and papers in high impact factor journals related to tissue engineering and Medical Education. Member of the Spanish Royal Academy of Medicine he has received three honoris causa doctorates in Argentina, Dominican Republic and Portugal.
Prof. Dr. Laura De Laporte, DWI - Leibniz Institute for Interactive Materials
Laura De Laporte designs Advanced Biomedical Systems that direct the interaction with cells. She studied Chemical Engineering in Ghent, where she got the tissue engineering microbe. During her PhD at Northwestern University, she engineered guiding implants for nerve regeneration, while her postdoc at EPFL in Jeffrey Hubbell’s group focused on smart hydrogels. Currently, she is a Leibniz Professor at the RWTH University and DWI-Leibniz Institute for Interactive Materials (Aachen, Germany). In her ERC Starting Grant Anisogel, her team designs low-invasive, polymeric hydrogel therapies that orient after injection to repair anisotropic tissues. In addition, dynamic hydrogels are created to study mechanobiology.
Dr. David Dean, The Ohio State University
In 1993 David Dean’s PhD thesis presented a template-based method for producing average 3D organ surface images. As a postdoctoral researcher at New York University he used average skull images as targets for surgical simulation and intra-operative guidance. Later at Case Western Reserve University he was the first person to use average surfaces to design and 3D print patient-specific cranial implants. His regenerative medicine research incorporates skeletal progenitor cells and 3D printing resorbable biomaterials. Since 2013 his research at The Ohio State University has included 3D printed NiTi for stiffness-matched skeletal fixation devices and Mg alloys for resorbable skeletal devices.
Prof. Dr. Benjamin Gantenbein, University of Bern
Prof Benjamin Gantenbein is heading the Tissue Engineering for Orthopedics & Mechanobiology (TOM) group at the Medical Faculty at the University of Bern (UBern). Prof Gantenbein acquired experience in modern concepts of tissue engineering and regenerative medicine. He is active in the field of tissue engineering, stem cell research (www.stemcellsbern.ch) using a wider range of bone & joint tissues. He teaches lectures on Tissue Engineering in the Biomedical Masters course at UBern and also teaches regenerative medicine at the University of Fribourg and the University of Basel.
Prof. Dr. Bernd Giebel, Institute for Transfusion Medicine
Bernd Giebel received his PhD 1996 at the University zu Köln in Developmental Biology. From 1999-2008 he worked at the Heinrich-Heine-University of Düsseldorf on human hematopoietic stem and progenitor cells and set up his own group. Continuing his stem cell research, in 2008 BG moved to the University Hospital Essen and as a 2nd topic started to work with EVs.
Prof. Jerome Guicheux, INSERM U1229-RMeS "Regenerative Medicine and skeleton research centre"
Jérôme Guicheux (50 yo, PhD-DSc 97’) is full professor/senior research director at the French national institute for health and medical research (INSERM). He is director of the research center RMES “regenerative medicine and skeleton” (120 people, INSERM U1229, Nantes, France). He is coordinator of the French INSERM osteoarthritis network. He is a member of the board of directors of OARSI and Regenerate-Biospine. He has authored more than 190 indexed publications (google scholar H-index 60, total citations >9000). His research focuses on the pathophysiology of skeletal tissues and biomaterials/stem cells-based regenerative medicine of cartilage and intervertebral disc. Researcher ID: F-7767-2013
Dr. Johannes Hackethal, THT Biomaterials GmbH
Dr. Hackethal finished his Master studies in “Tissue Engineering and Regenerative Medicine” at FH Technikum Vienna, Austria and “Medical biology” at Linköping University, Sweden. His doctoral thesis was performed at BOKU Vienna, Austria and the Ludwig-Boltzmann-Institute for Experimental and Clinical Traumatology under supervision of Prof.Dr. Heinz Redl (Hackethal et al., 2017. TEC 23(5); Hackethal et al., 2018. Advances in Experimental Medicine and Biology, DOI 10.1007/97898113094721, PCT/EP2019/058534). After finishing pHD, in June 2020, Dr. Hackethal founded THT Biomaterials GmbH, with the aim, to realize an affordable, sustainable and personalized Medicine by use of non-cellular human proteins from placenta.
Prof. Jinah Jang, Pohang University of Science and Technology
Dr. Jinah Jang received her PhD at Pohang University of Science and Technology (POSTECH) in Korea, and trained as postdoctoral fellow in POSTECH and Institute for Stem Cell and Regenerative Medicine at University of Washington. She has joined the POSTECH in 2017 as an assistant professor in the Creative IT Engineering, Mechanical Engineering, and School of Interdisciplinary Bioscience and Bioengineering. She has published 57 peer-reviewed articles in journals including Science Advances, Nature Communications, and Biomaterials (H-index: 24). Her research interest lies in engineering the functional human tissues using high-performance stem cells and printable biomaterials via the 3D bioprinting technology.
Prof. Julian Jones, Imperial College London
Julian Jones leads a research group on bioactive glasses and hybrids, particularly 3D scaffolds and therapeutic nanoparticles. He has >130 articles and 4 patent applications and has co-edited three biomaterials text books. He was elevated to Fellow of the Society for Glass Technology in 2018, Fellow of the American Ceramics Society in 2015; was awarded an ISCM (International Society for Ceramics in Medicine) Excellence Award in 2016; the 2014 Vittorio Gottardi Award from the International Commission on Glass (ICG). He is Chair-elect of the Bioceramics Division of the American Ceramics Society and Editor of the RSC Biomaterials Science Book Series.
Prof. David Kaplan, Tufts University
David Kaplan is the Stern Family Endowed Professor of Engineering at Tufts University, Distinguished University Professor, and Professor and Chair of the Department of Biomedical Engineering. His research focus is on biopolymer engineering to understand structure-function relationships and on tissue engineering and regenerative medicine. His lab has published over 900 peer reviewed papers, he is the editor-in-chief of ACS Biomaterials Science and Engineering, and he serves on many editorial boards and programs for journals and universities, and has received a number of awards for teaching and research.
Prof. Dr. Masahiro Kino-oka, Department of Biotechnology, Osaka University
Masa (Masahiro KINO-OKA) is one of leaders in the field of cell manufacturing, who contributes to the standardization of the cell processing facility and manufacturing. His current research interests are “Bioprocess engineering” to establish the cell and tissue manufacturing system. Toward the current professional status, Masa earned the Ph.D. (chemical engineering) in 1996, and he spent one year as a visiting staff in the Department of Chemical Engineering, National Institute of Switzerland (ETH) in Zurich. After returning, he promoted twice in his five-year tenure, and he earned a current position of Professor in Biotechnology, Osaka University since 2009.
Dr. Nicholas Kurniawan, Eindhoven University of Technology
Dr. Nicholas Kurniawan is an Assistant Professor at the Department of Biomedical Engineering in Eindhoven University of Technology, the Netherlands. His research focuses on understanding how the physical and mechanical interactions between cells and cellular environments shape physiological tissue function and drive pathologies. His interdisciplinary team combines approaches from biophysics, mechanobiology, microfabrication, and cell biology with an outlook of exploiting cell–materials interactions for regenerative medicine applications. His work is supported by grants from the European Research Council, the Dutch Research Council, the Dutch Ministry of Economic Affairs and Climate Policy, and the Dutch Ministry of Education, Culture and Science.
Dr. Claudia Loebel, University of Pennsylvania
Claudia Loebel is currently a postdoctoral fellow in the laboratory of Professor Jason Burdick at the University of Pennsylvania (United States). She obtained her MD (2011) at the Martin-Luther University Halle-Wittenberg (Germany) and completed her PhD (2016) at ETH Zurich and the AO Research Institute (Switzerland). She has been awarded the Silver Medal of ETH and postdoctoral fellowships by the Swiss National Science Foundation and IBSA Foundation. Her research interests are on the development of biomaterial platforms to address specific problems related to tissue repair and therapeutic treatment.
Prof. Dr. Henning Madry, Universität des Saarlandes, Lehrstuhl für Experimentelle Orthopädie und Arthroseforschung
- MD in 1996 from Humboldt University, Berlin
- Resident, Department of Trauma Surgery, Charité Medical School, Berlin and Department of Orthopaedic Surgery, Saarland University
- Board-certified in Orthopaedic Surgery in 2004
- Postdoctoral fellow: Massachusetts General Hospital, Harvard Medical School and Massachusetts Institute of Technology
- Since 2009 Full Professor and Director of the Center of Experimental Orthopaedics at Saarland University with joint appointment in Department of Orthopaedic Surgery
- Research focus: Fundamental and translational aspects of osteoarthritis and cartilage repair. Clinical practice: Regenerative surgical treatments for cartilage defects of the knee and osteoarthritis
Prof. Alvaro Mata, University of Nottingham
Alvaro Mata is Professor in Biomedical Engineering and Biomaterials in the School of Pharmacy and the Department of Chemical and Environmental Engineering at the University of Nottingham. He holds a Doctor of Engineering Degree working with Prof. Shuvo Roy at the Cleveland Clinic prior to postdoctoral training working with Prof. Samuel Stupp at Northwestern University. His group aims to harness biomolecules and supramolecular events found in nature to develop innovative materials and biofabrication processes. His work has led to seven patents or patent applications and publications in journals including Nature Materials, Nature Chemistry, Nature Communications, and Advanced Functional Materials.
Prof. Francesco Nicotra, University of Milano-Bicocca
Francesco Nicotra professor of Organic Chemistry at University of Milano-Bicocca, Past-President of the IUPAC Division of Organic and Biomolecular Chemistry, Italian representative in the International Carbohydrate Organization. Scientific interests in Bio-organic chemistry, with particular attention to glycoscience. Recipient of the Award for innovation in research of the Italian Chemical Society; the Medal Berti for Research in Carbohydrate Chemistry and the Medal Quilico of the Division of Organic Chemistry of the Italian Chemical Society. Plenary and Keynote speaker in > 50 International Conferences. >200 publications, 18 chapters of books, 12 patents, H index 39 (Google Scholar), 34 (Scopus)
Prof. Sean Palecek, University of Wisconsin - Madison
Prof. Sean Palecek is the Milton J. and Maude Shoemaker Professor of Chemical and Biological Engineering at the University of Wisconsin – Madison, the Director for Research for the National Center for Cell Manufacturing Technologies, and Director for Research Innovation of the Forward BIO Institute. Prof. Palecek’s research group develops processes for biomanufacturing of cells and tissues from human pluripotent stem cells, with a current focus on cardiovascular and neurovascular lineages. They strive to engineer robust, scalable platforms to produce high quality cells and tissues for in vitro diagnostics as well as regenerative medicine applications.
Prof. Dr. Chanhum Park, Hallym University
I graduated the Hallym Univsersity Medical School(M.D.) in 1996. He obtained Ph.D. degree from KangWon National University, Korea. I have been working in chief(associate professor) of the department of Otorhinolaryngology Head & Neck Surgery in Chunchon Sacred Heart Hospital of Hallym Medical Center from 2004. My major study’s field of medical part is the facial surgery and reconstruction such as rhinoplasty, facial trauma, skin cancer etc. I studied the biomaterials for facial reconstruction such as Gore-Tex, Silicone, metal plate, absorbable fixation plate etc. And I was developing biomaterials using silk fibroin from 2008
Dr. Qasim Rafiq, University College London
Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocessing. He is a multidisciplinary engineer and currently leads a research portfolio of >£3.5m and heads up the ATMP Bioprocess Engineering group which includes 4 PDRAs and 12 PhD students. He is the Programme Director of a new MSc programme in the Manufacture and Commercialisation of Stem Cell and Gene Therapies. He is both a Chartered Engineer (CEng) and Chartered Scientist (CSci) and sits on multiple scientific and engineering committees including the BIA’s Cell and Gene Therapy Advisory Committee and BSI’s Biotechnology Standards Group.
Prof. José Carlos Rodríguez-Cabello, Bioforge Lab. University of Valladolid
Full Professor of condensed Matter Physics and CEO of Technical Proteins NBT S.L.. Expert in biomaterials and biomedical engineering. My research interest lies on the recombinant production of bioinspired polypeptides and the use of those designed macromolecules in a broad range of applications from more basic science around self-organization and order-disorder interplay in natural proteins to the use of such materials in regenerative medicine and nanomedicine.
Prof. Hazel Screen, Queen Mary University of London
Hazel Screen is Professor of Biomedical Engineering at Queen Mary University of London. Her research centres on healthy and pathological tissue structure-function behaviour and its interplay with mechanobiology. She has a particular interest in tendon and ligament, and leads a highly multidisciplinary group which spans human and animal in vivo and in vitro studies of tendon function and injury. She also leads the UK Organ-on-a-Chip Technologies Network and is interested in developing novel in vitro models of musculoskeletal tissues which integrate learning from structure-function studies to recapitulate appropriate physiochemical cues.
Prof. Dr. Dimitrios Stamatialis, University of Twente
Prof. Dr. Dimitrios Stamatialis obtained his PhD at NRC “Demokritos” (Athens - Greece) in 1995 in the field of physical chemistry and membranes. He is full professor of (bio)artificial organs at the University of Twente in the Netherlands.
Prof. Stamatialis has been involved in numerous projects leading to products and applications, some licensed to companies. He is author of more than 145 scientific papers and inventor of 9 patents. He has various international activities, including: Chairman of the working group on bioartificial organs of the European Society of artificial organs (ESAO) and editor of the “international journal of artificial organs”.
Prof. Dr. Yasuhiko Tabata, Institute for Frontier Life and Medical Sciences, Kyoto University
Dr. Yasuhiko Tabata is the Professor of Institute for Frontier Life and Medical Sciences, Kyoto University and guest professors of 17 different universities. He received his BD in Polymer Chemistry (1981), Ph.D. (1988) in Technology, D.Med.Sc. (2002), and D.Pharm. (2003) all at Kyoto University. He was a Visiting Scientist at the MIT (Professor Robert Langer) (1991-92). He has published 1,630 scientific papers including 145 book chapters and review articles, and has 130 patents. He received the Scientific Award from the Japanese Society for Biomaterials (2002), the Japan Society of Drug Delivery System (2011), TERMIS-AP (2018), and 5 other scientific awards.
Dr. Masayo Takahashi, Vision Care Inc.
Masayo Takahashi received her M.D. and Ph.D. from Kyoto University. She moved to the Salk Institute, where she discovered the potential of stem cells as a tool for retinal therapy. She joined RIKEN as a Team Leader. In 2013, her team launched a pilot clinical study of autologous iPS cell-derived RPE cell sheets for exudative aged-related macular degeneration, and performed the first RPE cell sheet graft transplantation in 2014. In 2019, she started a new carrier as a president of start-up company; Vision Care Inc. Her aim is to understand these diseases at a fundamental level and develop retinal therapies.
Dr. Hironobu Takahashi, Tokyo Women's Medical University
Dr. Takahashi is now an associate professor of Institute of Advanced Biomedical Engineering and Science at Tokyo Women’s Medical University (TWMU). He graduated from Department of Engineering, Kyushu University and received Ph.D. in 2006. He then performed postdoctoral research under Prof. David Grainger, Colorado State University and University of Utah, USA. His researches was the development of a hydrogel-based local drug delivery system and cell micropatterning techniques. After that, he moved to TWMU and started researches for tissue engineering and regenerative medicine in 2008. His recent work is focused on muscle tissue engineering for the development of in-vitro tissue model.
Prof. Pierre vanderhaeghen, VIB Belgium
Pierre Vanderhaeghen is Professor at the VIB Center for Brain and Disease Research at KU Leuven, and Université Libre de Bruxelles, Belgium. His research is focused the mechanisms of development of the cerebral cortex in direct link with human brain evolution and diseases. His lab uses classical tools such as mouse genetics and embryology, as well as innovative models of corticogenesis from pluripotent stem cells, which were pioneered in his lab.
Dr. Joaquim Vives, Banc de Sang i Teixits
I am a Biochemist with extensive experience in the R&D biotech sector, both in private and academic environments. I focused my career on the optimisation of cellular processes towards A) high yield production of diagnostic and therapeutic molecules, and B) the development of methods to produce cells for drug screening and therapy, in compliance with current regulatory and quality standards. Apart from leading MTA production for clinical trials, I focus my research in A) the generation of 3D tissue engineering products, B) the development of animal models for the study of tissue regeneration and identification of biomarkers of tissue remodelling.
Dr. Yoram Vodovotz, University of Pittsburgh
Dr. Yoram Vodovotz is currently a Professor of Surgery, Immunology, Computational and Systems Biology, Bioengineering, Clinical and Translational Science, and Communication Science and Disorders at the University of Pittsburgh School of Medicine. His research focus is the systems biology of inflammation. He is the Director of the Center for Inflammation and Regeneration Modeling (CIRM; http://www.mirm.pitt.edu/our-research/centers/center-for-inflammation-an...) at the McGowan Institute for Regenerative Medicine, a co-founder and past President of the Society for Complex Acute Illness (www.scai-med.org), and a co-founder of Immunetrics, Inc. (www.immunetrics.com), a Pittsburgh-based company that is commercializing this mathematical modeling work. He has published over 300 manuscripts.
Prof. Slobodan Vukicevic, Laboratory for Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine
Slobodan Vukicevic is a full professor and head of Laboratory of Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine. He is a full member of the Croatian Academy of Sciences and Arts. His scientific interests comprise bone and cartilage morphogenetic proteins and development of drugs for regeneration of bone, kidney and heart muscle. Inventor of more than 30 patents and editor of 4 books on BMPs. Founder of Genera Research, innovation-based biotechnology company developing a novel regenerative therapy for bone defects via coordinating collaborative programs OSTEOGROW (FP7) and OSTEOproSPINE (HORIZON 2020).
Prof. Wolfgang Wagner, RWTH Aachen Medical School
Wolfgang Wagner is Professor of Stem Cell Biology and Cellular Engineering at RWTH Aachen University Medical School (Germany) since 10 years. Furthermore, he is cofounder of the company Cygenia (www.cygenia.com) that provides service for epigenetic analysis for other scientists since 2014. Prof. Wagner is Editor of the journals PLoS ONE, Scientific Reports and Clinical Epigenetics. His main research interests are 1) epigenetics in hematopoietic differentiation; 2) standardization and characterization of mesenchymal stem cells; 3) interaction of stem cells with biomaterials; and 4) molecular and epigenetic effects of aging, replicative senescence, and malignant transformation.
Dr. Gerlinde Van De Walle, Cornell university
Dr. Van de Walle received her DVM degree from the Faculty of Veterinary Medicine, Ghent University, Belgium, followed by a PhD from the same institution. She is currently an Associate Professor at the Baker Institute for Animal Health, Cornell University, where she runs her research lab working in the fields of Virology and Stem Cell Biology. In 2016, she was awarded the Zoetis Animal Health Award for Research Excellence, and was named the Harry M. Zweig Assistant Professor in Equine Health in 2017. She has published over 100 papers in peer-reviewed journals and presented at numerous national and international conferences.
Prof. Matthew Webber, University of Notre Dame
Assistant Professor of Chemical & Biomolecular Engineering, University of Notre Dame, USA.
Prof. Dr. Regine Willumeit-Römer, Helmholtz Zentrum Geesthacht, Metallische Biomaterialien
R. Willumeit-Römer studied and obtained a PhD in physics by working on the structure of ribosomes. Habilitation and venia legendi in biochemistry. After working on peptide antibiotics and antimicrobial implant surfaces focus on degradable Mg-based implants. Current position: Director of the Institute for Materials Research, Divison Metallic Biomaterials, Helmholtz-Center Geesthacht and Professor at the Faculty of Engineering, Christian-Albrechts-University, Kiel, Germany.
Prof. Dr. Tobias Winkler, Universitätsmedizin Berlin / Regenerative Orthopädie und Unfallchirurgie
Prof. Dr. Tobias Winkler is orthopedic and trauma surgeon at the Center for Muskuloskeletal Surgery (CMSC) of the Charité Berlin. He is coordinator of an international research consortium performing the worldwide only phase III trial of an allogeneic cell therapy for regeneration after skeletal muscle injury. He is head of a research team, which main focus is the translation of advanced therapies for musculoskeletal indications. His research work in the field encompasses cell therapies with adult mesenchymal and blood cells for bone tendon and muscle regeneration and the development of biomaterials for bone regeneration.
Dr. Yang Zhang, Shenzhen University
Yang Zhang obtained his Ph.D. degree and postdoctoral experience from Radboud University Medical Center, the Netherlands. After that, he joined Shenzhen University as an associate professor. His current research focuses on unraveling roles of the immune microenvironment in tissue regeneration, where he has published more than 20 journal articles. He served as a 29th ESB Academic Committee member and as a peer reviewer for Biomaterials Science, Tissue Engineering, Journal of Biomedical Materials Research, etc. He was also a visiting researcher at Johannes Gutenberg University Mainz (Germany) and Capital Medical University (China).